Unum Group Stock

Equities

UNM

US91529Y1064

Life & Health Insurance

Market Closed - Nyse 04:00:02 2024-04-18 pm EDT 5-day change 1st Jan Change
50.79 USD +1.26% Intraday chart for Unum Group +1.07% +12.32%
Sales 2024 * 12.96B Sales 2025 * 13.46B Capitalization 9.75B
Net income 2024 * 1.51B Net income 2025 * 1.53B EV / Sales 2024 * 0.75 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.72 x
P/E ratio 2024 *
6.46 x
P/E ratio 2025 *
6.05 x
Employees 10,683
Yield 2024 *
3.05%
Yield 2025 *
3.34%
Free-Float 98.51%
More Fundamentals * Assessed data
Dynamic Chart
Morgan Stanley Adjusts Unum Group's Price Target to $52 From $50, Keeps Equalweight Rating MT
Unum Group Keeps Quarterly Dividend at $0.365 per Share, Payable May 17 to Stockholders of Record April 26 MT
Unum Group Declares Quarterly Dividend on Its Common Stock, Payable on May 17, 2024 CI
Wells Fargo Raises Unum Group's Price Target to $66 From $64, Keeps Overweight Rating MT
JPMorgan Raises Unum Group Price Target to $58 From $56, Maintains Overweight Rating MT
Unum Insider Sold Shares Worth $510,600, According to a Recent SEC Filing MT
Unum Launches Unum Care Hub CI
Transcript : Unum Group Presents at UBS Financial Services Conference 2024, Feb-28-2024 10:30 AM
Tuned Care, Inc. announced that it has received $3.2 million in funding from Unum Group, Distributed Ventures CI
Tuned Care, Inc. announced that it has received $5.7 million in funding from Elements Health Ventures, Idealab NY, Inc., Unum Group, Distributed Ventures CI
Tuned Care, Inc. announced that it has received $6.7 million in funding from Idealab NY, Inc., Elements Health Ventures, Distributed Ventures, Unum Group CI
TriNet Q4 Adjusted Net Income, Revenue Rise; CEO to Retire -- Shares Rise After Hours MT
UBS Adjusts Unum Group Price Target to $53 From $51, Maintains Neutral Rating MT
Wells Fargo Adjusts Price Target on Unum to $64 From $61, Maintains Overweight Rating MT
Citigroup Adjusts Price Target on Unum to $62 From $58, Maintains Buy Rating MT
More news
1 day+1.26%
1 week+1.07%
Current month-5.35%
1 month-2.16%
3 months+10.73%
6 months-0.78%
Current year+12.32%
More quotes
1 week
49.69
Extreme 49.685
51.12
1 month
49.69
Extreme 49.685
54.57
Current year
44.83
Extreme 44.83
54.57
1 year
40.04
Extreme 40.04
54.57
3 years
22.25
Extreme 22.25
54.57
5 years
9.58
Extreme 9.58
54.57
10 years
9.58
Extreme 9.58
58.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 09-07-19
Director of Finance/CFO 55 13-08-04
Chief Tech/Sci/R&D Officer 61 18-03-07
Members of the board TitleAgeSince
Chief Executive Officer 55 09-07-19
Director/Board Member 62 12-08-14
Director/Board Member 68 14-07-31
More insiders
Date Price Change Volume
24-04-18 50.79 +1.26% 1,099,442
24-04-17 50.16 -0.46% 784,609
24-04-16 50.39 +0.88% 1,152,769
24-04-15 49.95 -0.70% 974,339
24-04-12 50.3 +0.10% 1,465,388

Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT

More quotes
Unum Group is a provider of workplace benefits and services. The Company provides financial protection benefits in the United States and the United Kingdom (UK). Its products include disability, life, accident, critical illness, dental and vision, and other related services. The Company has three segments: Unum US, Unum International, and Colonial Life. Its Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. Its Unum International segment includes its operations in the UK and Poland. Unum UK's business includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and others. Unum Poland's business includes insurance for individual and group life with accident and health riders. Its Colonial Life segment includes accident, sickness, and disability products, life products, and cancer and critical illness products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
50.79 USD
Average target price
58.6 USD
Spread / Average Target
+15.38%
Consensus